This HTML5 document contains 104 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n13https://scigraph.springernature.com/pub.10.1023/a:
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n10http://dx.doi.org/10.1023/A:
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q73905120
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel наукова стаття, опублікована в травні 2000 im Mai 2000 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 May 2000 artículu científicu espublizáu en mayu de 2000
p:P577
wds:Q73905120-9F7D230F-9DCE-456D-BF33-861868CFB283
wdt:P577
2000-05-01T00:00:00Z
p:P2888
wds:Q73905120-505DA882-0B82-4578-A101-E68B76F868A3
wdt:P2888
n13:1006313611677
p:P2860
wds:Q73905120-ED6C68E0-2748-4F4F-AAE6-1E7C023E0F98 wds:Q73905120-F2A9CFE4-8746-49D7-8B76-E5AED95801F3 wds:Q73905120-F7548F02-2C66-41A4-A5BD-03348052FCF1 wds:Q73905120-E821DEF6-A14D-43F6-8388-9D626E66C742 wds:Q73905120-ED6A9329-0643-44C1-86AD-C94EC4418FB3 wds:Q73905120-327E2FF9-1191-493C-B58F-E3C22CF9834E wds:Q73905120-822690C3-40C2-4C7F-A4A0-C7F0A98EFEAF wds:Q73905120-88628A5D-661D-4028-B5A0-0E8349243018 wds:Q73905120-98C4DE24-F046-4051-B2D1-63C3945A9A96 wds:Q73905120-6D310823-1E79-4D4E-B492-331B50F071FA wds:Q73905120-7527B124-44CD-4A38-A52C-BB390029D446 wds:Q73905120-759DE3C7-E5AB-4628-AD42-6CE1E0A5FBAC wds:Q73905120-537E43BC-BCCC-46DE-B004-7487E0767D92 wds:Q73905120-685A78A9-18BC-4400-A03C-08A26E671D92 wds:Q73905120-36C277EB-7E2B-4705-9700-982AF7A2A3E1 wds:Q73905120-456702BB-4CB0-4AC9-9D0E-69BAF6096D7A wds:Q73905120-CD337C1B-50BA-4D84-BFEE-88A850037BB2 wds:Q73905120-DF2491BB-A885-4902-8655-42FD543A44B7 wds:Q73905120-E7823B62-5BD1-4220-A4F7-0144D2485319 wds:Q73905120-BAE34E51-89DE-4CB0-8717-FCBB9874DC81 wds:Q73905120-BFB7479C-6A84-4AC2-BC6F-F84D2730CC2E wds:Q73905120-C3AE8864-45D2-4C94-9196-A5EBFF93572C wds:Q73905120-C850DDBD-77DD-40D5-AC25-9C4444834212 wds:Q73905120-A012D139-BF23-4628-B5EB-755F56FC3F0E wds:Q73905120-A4BD3C86-2629-43D0-B1B0-1E3536C33020 wds:Q73905120-A6C1F8C1-9A3C-46CE-B531-908B6F3607FB wds:Q73905120-AF57D372-B6C5-4218-B4B1-F9D6E5D1341F wds:Q73905120-9947676B-45FD-405F-8932-A24C0BA0D68F
wdt:P2860
wd:Q71874751 wd:Q37794779 wd:Q41679901 wd:Q41354263 wd:Q40994759 wd:Q73722591 wd:Q50537563 wd:Q70862363 wd:Q41077781 wd:Q70733013 wd:Q40027086 wd:Q55479543 wd:Q47704520 wd:Q41226364 wd:Q35790615 wd:Q29615418 wd:Q41308629 wd:Q72078498 wd:Q41007087 wd:Q54114456 wd:Q77556919 wd:Q73235623 wd:Q42215353 wd:Q44781213 wd:Q73501508 wd:Q40911094 wd:Q69503287 wd:Q40258539
p:P2093
wds:Q73905120-E89D831A-0928-46A5-A209-1D303A38B958 wds:Q73905120-D58EA998-5D8F-4796-AB15-83D575275075 wds:Q73905120-9AEF476F-116D-4650-9F19-D11423B95C0C wds:Q73905120-41DFAB43-9D69-4A1A-ABC2-F6C61545E35C wds:Q73905120-69ADE80A-ED85-4BFA-9BA6-7542B8174E7F wds:Q73905120-584F1381-F388-4993-884C-9FAF3ACA3A74
wdt:P2093
J W Connelly C D Hose E A Sausville A Monks A Vaigro-Wolff E D Harris
rdfs:label
UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines
skos:prefLabel
UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines
schema:name
UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines
p:P1476
wds:Q73905120-02F6D4B8-F1A3-44C4-967D-80183C712693
wdt:P1476
UCN-01 enhances the in vitro toxicity of clinical agents in human tumor cell lines
p:P304
wds:Q73905120-067E2705-1239-43D8-AE2F-62F4B39FA88E
wdt:P304
95-107
p:P31
wds:Q73905120-2B59A5EA-5245-40BA-AAFF-0B17B75B33BD
wdt:P31
wd:Q13442814
p:P698
wds:Q73905120-E97C37FB-E1B0-495C-BE68-5DC3B806B8AD
wdtn:P698
n12:10857990
wdt:P698
10857990
p:P1433
wds:Q73905120-345A21B1-7A62-4B5B-A99F-455FC25948A4
wdt:P1433
wd:Q2312231
p:P433
wds:Q73905120-6AA16967-0738-4A70-AB88-D9CECAD984B3
p:P478
wds:Q73905120-EDE98D08-70A0-45F6-AB36-B6B4863F17A5
wdt:P433
2
wdt:P478
18
p:P356
wds:Q73905120-9692DFDD-00D2-49E7-B839-11E28511FE11
wdtn:P356
n10:1006313611677
wdt:P356
10.1023/A:1006313611677
p:P6179
wds:Q73905120-98C83B41-02EC-42BF-A573-D7FD888ECB5F
wdt:P6179
1049551653